Showing results (121-130 of 165) with videos related to
Sort By:
Pageof 17
Antimicrobial Agents and Chemotherapy|December 24, 2004
Pharmacokinetics of oritavancin in plasma and skin blister fluid following administration of a 200-milligram dose for 3 days or a single 800-milligram doseGerald J Fetterly, Christine M Ong, Sujata M Bhavnani, et al.The Journal of Antimicrobial Chemotherapy|February 22, 2020
Methodological features of clinical pharmacokinetic-pharmacodynamic studies of antibacterials and antifungals: a systematic reviewAlexandra McAleenan, Paul G Ambrose, Sujata M Bhavnani, et al.Journal of Pharmacokinetics and Pharmacodynamics|March 30, 2017
PK-PD Compass: bringing infectious diseases pharmacometrics to the patient's bedsideCatharine C Bulik, Justin C Bader, Li Zhang, et al.Antimicrobial Agents and Chemotherapy|March 14, 2018
Evaluation of Ceftolozane-Tazobactam in Combination with Meropenem against Pseudomonas aeruginosa Sequence Type 175 in a Hollow-Fiber Infection ModelM Montero, Brian D VanScoy, Carla López-Causapé, et al.Antimicrobial Agents and Chemotherapy|November 27, 2013
Pharmacokinetic-pharmacodynamic target attainment analyses to evaluate in vitro susceptibility test interpretive criteria for ceftaroline against Staphylococcus aureus and Streptococcus pneumoniaeScott A Van Wart, Paul G Ambrose, Christopher M Rubino, et al.Antimicrobial Agents and Chemotherapy|May 20, 2009
Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infectionOlanrewaju O Okusanya, Sujata M Bhavnani, Jeffrey Hammel, et al.Antimicrobial Agents and Chemotherapy|September 12, 2007
Evaluation of tigecycline penetration into colon wall tissue and epithelial lining fluid using a population pharmacokinetic model and Monte Carlo simulationChristopher M Rubino, Lei Ma, Sujata M Bhavnani, et al.Antimicrobial Agents and Chemotherapy|July 30, 2014
Relationship between ceftolozane-tazobactam exposure and selection for Pseudomonas aeruginosa resistance in a hollow-fiber infection modelBrian D VanScoy, Rodrigo E Mendes, Mariana Castanheira, et al.Journal of Leukocyte Biology|July 22, 2005
Flagellin enhances NK cell proliferation and activation directly and through dendritic cell-NK cell interactionsHironori Tsujimoto, Takefumi Uchida, Philip A Efron, et al.The Journal of Infectious Diseases|May 6, 2017
White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-Spectrum Indications, and Unmet NeedsHelen W Boucher, Paul G Ambrose, H F Chambers, et al.Pageof 17